{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:47:06Z","timestamp":1788914826108,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.sapharm.2019.06.011","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T05:12:30Z","timestamp":1561180350000},"page":"422-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Environmental and individual predictors of medication adherence among elderly patients with hypertension and chronic kidney disease: A geospatial approach"],"prefix":"10.1016","volume":"16","author":[{"given":"Yun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Saran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Hirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Balkrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 Suppl 1","key":"10.1016\/j.sapharm.2019.06.011_bib1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.sapharm.2019.06.011_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-159-12-201312170-00726","article-title":"Clinical Guidelines Committee of the American College of Physicians. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians","volume":"159","author":"Qaseem","year":"2013","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.sapharm.2019.06.011_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s10157-016-1312-6","article-title":"Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study","volume":"21","author":"Tangkiatkumjai","year":"2017","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"10.1016\/j.sapharm.2019.06.011_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.ajkd.2010.02.348","article-title":"Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study","volume":"56","author":"Muntner","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.sapharm.2019.06.011_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000321688","article-title":"Adherence to antihypertensive agents and blood pressure control in chronic kidney disease","volume":"32","author":"Schmitt","year":"2010","journal-title":"Am J Nephrol"},{"issue":"13","key":"10.1016\/j.sapharm.2019.06.011_bib6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.sapharm.2019.06.011_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.HYP.0000164577.81087.70","article-title":"Control of hypertension in adults with chronic kidney disease in the United States","volume":"45","author":"Peralta","year":"2005","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.sapharm.2019.06.011_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1590\/S0100-879X2011007500013","article-title":"Adherence to drug therapy in kidney disease","volume":"44","author":"Magacho","year":"2011","journal-title":"Braz J Med Biol Res"},{"issue":"4 Suppl","key":"10.1016\/j.sapharm.2019.06.011_bib9","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0197-2456(97)82680-3","article-title":"Appointment attendance, pill counts, and achievement of goal blood pressure in the african American study of kidney disease and hypertension pilot study","volume":"17","author":"Lee","year":"1996","journal-title":"Contr Clin Trials"},{"issue":"1","key":"10.1016\/j.sapharm.2019.06.011_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/jhh.2015.26","article-title":"Medication adherence and visit-to-visit variability of systolic blood pressure in African Americans with chronic kidney disease in the AASK trial","volume":"30","author":"Hong","year":"2016","journal-title":"J Hum Hypertens"},{"issue":"4","key":"10.1016\/j.sapharm.2019.06.011_bib11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2215\/CJN.07290810","article-title":"Kidney function and long-term medication adherence after myocardial infarction in the elderly","volume":"6","author":"Chang","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.sapharm.2019.06.011_bib12","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ijnurstu.2008.07.002","article-title":"Adherence to multiple, prescribed medications in diabetic kidney disease: a qualitative study of consumers' and health professionals' perspectives","volume":"45","author":"Williams","year":"2008","journal-title":"Int J Nurs Stud"},{"issue":"3","key":"10.1016\/j.sapharm.2019.06.011_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/j.ajkd.2010.04.021","article-title":"Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study","volume":"56","author":"Rifkin","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.sapharm.2019.06.011_bib14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1755-6686.2013.12037.x","article-title":"Patients' experience and perceptions of polypharmacy in chronic kidney disease and its impact on adherent behaviour","volume":"39","author":"McKillop","year":"2013","journal-title":"J Ren Care"},{"issue":"12","key":"10.1016\/j.sapharm.2019.06.011_bib15","first-page":"1208","article-title":"Geospatial analysis of statin adherence using pharmacy claims data in the state of Michigan","volume":"20","author":"Erickson","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"issue":"10","key":"10.1016\/j.sapharm.2019.06.011_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1592\/phco.31.10.927","article-title":"Mapping geographic areas of high and low drug adherence in patients prescribed continuing treatment for acute coronary syndrome after discharge","volume":"31","author":"Hoang","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.sapharm.2019.06.011_bib17","first-page":"834","article-title":"Geographic variation in medication adherence in commercial and Medicare part D populations","volume":"20","author":"Couto","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"issue":"3 Pt 1","key":"10.1016\/j.sapharm.2019.06.011_bib18","first-page":"571","article-title":"Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization","volume":"33","author":"Phillips","year":"1998","journal-title":"Health Serv Res"},{"key":"10.1016\/j.sapharm.2019.06.011_bib19","first-page":"Doc11","article-title":"Re-revisiting andersen's behavioral model of health services use: a systematic review of studies from 1998-2011","volume":"9","author":"Babitsch","year":"2012","journal-title":"Psycho Soc Med"},{"key":"10.1016\/j.sapharm.2019.06.011_bib20","unstructured":"US Census Bureau Geography Reference. Centers of Population. http:\/\/www.census.gov\/geo\/reference\/centersofpop.html. Accessed June 18, 2019."},{"issue":"3S1","key":"10.1016\/j.sapharm.2019.06.011_bib21","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2018.01.002","article-title":"US renal data system 2017 annual data report: Epidemiology of kidney disease in the United States","volume":"71","author":"Saran","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.sapharm.2019.06.011_bib22","first-page":"449","article-title":"Estimating medication persistency using administrative claims data","volume":"11","author":"Sikka","year":"2005","journal-title":"Am J Manag Care"},{"issue":"6","key":"10.1016\/j.sapharm.2019.06.011_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2019.06.011_bib24","unstructured":"Townsend Deprivation Index. http:\/\/www.restore.ac.uk\/geo-refer\/36229dtuks00y19810000.php. Accessed June 18, 2019."},{"key":"10.1016\/j.sapharm.2019.06.011_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/gean.12084","article-title":"The multiple testing issue in geographically weighted regression","volume":"48","author":"da Silva","year":"2016","journal-title":"Geogr Anal"},{"issue":"2","key":"10.1016\/j.sapharm.2019.06.011_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1179\/000870406X114658","article-title":"Mapping the results of geographically weighted regression","volume":"43","author":"Mennis","year":"2006","journal-title":"Cartogr J"},{"key":"10.1016\/j.sapharm.2019.06.011_bib27","author":"Nakaya"},{"issue":"1","key":"10.1016\/j.sapharm.2019.06.011_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/002214650504600103","article-title":"Neighborhood socioeconomic disadvantage and access to health care","volume":"46","author":"Kirby","year":"2005","journal-title":"J Health Soc Behav"},{"key":"10.1016\/j.sapharm.2019.06.011_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1476-072X-10-44","article-title":"A spatial analysis of variations in health access: linking geography, socio-economic status and access perceptions","volume":"10","author":"Comber","year":"2011","journal-title":"Int J Health Geogr"},{"key":"10.1016\/j.sapharm.2019.06.011_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12061-009-9021-0","volume":"2","author":"Bagheri","year":"2009","journal-title":"Appl. Spatial Analysis"},{"issue":"4","key":"10.1016\/j.sapharm.2019.06.011_bib31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/107755802237808","article-title":"Access to medical care for low-income persons: how do communities make a difference?","volume":"59","author":"Andersen","year":"2002","journal-title":"Med Care Res Rev"},{"issue":"9","key":"10.1016\/j.sapharm.2019.06.011_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jech.2005.045567","article-title":"Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998","volume":"62","author":"King","year":"2008","journal-title":"J Epidemiol Community Health"},{"issue":"11","key":"10.1016\/j.sapharm.2019.06.011_bib33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.mlr.0000228025.04535.25","article-title":"Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002","volume":"44","author":"Zerzan","year":"2006","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.sapharm.2019.06.011_bib34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jdiacomp.2012.04.001","article-title":"Geographic variation in pharmacotherapy decisions for U.S. Medicare enrollees with diabetes","volume":"26","author":"Sargen","year":"2012","journal-title":"J Diabet Complicat"},{"issue":"4","key":"10.1016\/j.sapharm.2019.06.011_bib35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11606-012-2244-9","article-title":"Receipt of high risk medications among elderly enrollees in Medicare Advantage plans","volume":"28","author":"Qato","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.sapharm.2019.06.011_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research","volume":"42","author":"DiMatteo","year":"2004","journal-title":"Med Care"},{"issue":"11","key":"10.1016\/j.sapharm.2019.06.011_bib37","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.sapharm.2019.06.011_bib38","series-title":"The impact of Medicare Part D coverage on medication adherence and health outcomes in end-stage renal disease (ESRD) patients","author":"Park","year":"2013"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741119300191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741119300191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:17:37Z","timestamp":1761556657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741119300191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1551741119300191"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2019.06.011","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Environmental and individual predictors of medication adherence among elderly patients with hypertension and chronic kidney disease: A geospatial approach","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2019.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}